These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9974188)

  • 1. The rat Subcutaneous Air Sac model: a quantitative assay of antiangiogenesis in induced vessels.
    Lichtenberg J; Hjarnaa PJ; Kristjansen PE; Hansen D; Binderup L
    Pharmacol Toxicol; 1999 Jan; 84(1):34-40. PubMed ID: 9974188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rat subcutaneous air sac model: a new and simple method for in vivo screening of antiangiogenesis.
    Lichtenberg J; Hansen CA; Skak-Nielsen T; Bay C; Mortensen JT; Binderup L
    Pharmacol Toxicol; 1997 Dec; 81(6):280-4. PubMed ID: 9444670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent.
    Kusaka M; Sudo K; Fujita T; Marui S; Itoh F; Ingber D; Folkman J
    Biochem Biophys Res Commun; 1991 Feb; 174(3):1070-6. PubMed ID: 1705118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of the antiangiogenic agent TNP-470 on establishment and growth of hematogenous metastasis of human pancreatic carcinoma in SCID beige mice in vivo.
    Kawarada Y; Ishikura H; Kishimoto T; Saito K; Takahashi T; Kato H; Yoshiki T
    Pancreas; 1997 Oct; 15(3):251-7. PubMed ID: 9336788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of fumagillin and its analogue TNP-470 on the function, morphology and angiogenesis of an oestrogen-induced prolactinoma in Fischer 344 rats.
    Stepień H; Grochal M; Zieliński KW; Mucha S; Kunert-Radek J; Kulig A; Stawowy A; Pisarek H
    J Endocrinol; 1996 Jul; 150(1):99-106. PubMed ID: 8708569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumour effect of a synthetic analogue of fumagillin on murine renal carcinoma.
    Morita T; Shinohara N; Tokue A
    Br J Urol; 1994 Oct; 74(4):416-21. PubMed ID: 7529632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of the angiogenesis inhibitor TNP-470 on tumor growth and metastasis in nude mice bearing human hepatocellular carcinoma.
    Xia JL; Yang BH; Tang ZY; Sun FX; Xue Q; Gao DM
    J Cancer Res Clin Oncol; 1997; 123(7):383-7. PubMed ID: 9260590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic agent (TNP-470) inhibition of ectopic bone formation induced by bone morphogenetic protein-2.
    Mori S; Yoshikawa H; Hashimoto J; Ueda T; Funai H; Kato M; Takaoka K
    Bone; 1998 Feb; 22(2):99-105. PubMed ID: 9477232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An antiangiogenic agent (TNP-470) inhibited reoxygenation during fractionated radiotherapy of murine mammary carcinoma.
    Murata R; Nishimura Y; Hiraoka M
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1107-13. PubMed ID: 9169820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470; AGM-1470).
    Yamaoka M; Yamamoto T; Masaki T; Ikeyama S; Sudo K; Fujita T
    Cancer Res; 1993 Sep; 53(18):4262-7. PubMed ID: 7689930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of angiogenesis inhibitor TNP-470 on vascular formation in pituitary tumors induced by estrogen in rats.
    Takechi A
    Neurol Med Chir (Tokyo); 1994 Nov; 34(11):729-33. PubMed ID: 7533265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined effects of an angiogenesis inhibitor (TNP-470) and hyperthermia.
    Nishimura Y; Murata R; Hiraoka M
    Br J Cancer; 1996 Feb; 73(3):270-4. PubMed ID: 8562329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effect of TNP-470 is not associated to decrease of angiogenesis in an experimental malignant neuroectodermic tumor.
    Morales C; Zurita M; Vaquero J
    J Neurooncol; 2002 Jun; 58(2):131-6. PubMed ID: 12164684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of TNP-470, a potent angiogenesis inhibitor, on growth of hematopoietic progenitors.
    Hasuike T; Hino M; Yamane T; Nishizawa Y; Morii H; Tatsumi N
    Eur J Haematol; 1997 Apr; 58(4):293-4. PubMed ID: 9186544
    [No Abstract]   [Full Text] [Related]  

  • 15. TNP-470 (AGM-1470): mechanisms of action and early clinical development.
    Castronovo V; Belotti D
    Eur J Cancer; 1996 Dec; 32A(14):2520-7. PubMed ID: 9059342
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibitory effects of roxithromycin on tumor angiogenesis, growth and metastasis of mouse B16 melanoma cells.
    Yatsunami J; Tsuruta N; Fukuno Y; Kawashima M; Taniguchi S; Hayashi S
    Clin Exp Metastasis; 1999 Mar; 17(2):119-24. PubMed ID: 10411103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-angiogenic compound (TNP-470) inhibits mesangial cell proliferation in vitro and in vivo.
    Haraguchi M; Okamura M; Konishi M; Konishi Y; Negoro N; Inoue T; Kanayama Y; Yoshikawa J
    Kidney Int; 1997 Jun; 51(6):1838-46. PubMed ID: 9186873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plausible novel therapeutic strategy of uterine endometrial cancer with reduction of basic fibroblast growth factor secretion by progestin and O-(chloroacetyl-carbamoyl) fumagillol (TNP-470; AGM-1470).
    Fujimoto J; Hori M; Ichigo S; Hirose R; Sakaguchi H; Tamaya T
    Cancer Lett; 1997 Feb; 113(1-2):187-94. PubMed ID: 9065821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2.
    Sin N; Meng L; Wang MQ; Wen JJ; Bornmann WG; Crews CM
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6099-103. PubMed ID: 9177176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of the anti-angiogenesis drug TNP-470.
    Gervaz P; Fontolliet C
    Int J Exp Pathol; 1998 Dec; 79(6):359-62. PubMed ID: 10319017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.